Eligible patients with clinical stage II or III , excluding T4 , squamous cell carcinoma were randomized to undergo surgery followed ( group 1 ) or preceded ( group 2 ) by chemotherapy consisting of two courses of cisplatin plus 5-fluorouracil .
